学术探索
学术期刊
新闻热点
数据分析
智能评审

Cardiovascular Comorbidities of Psoriasis and Psoriatic Arthritis: A Report from the GRAPPA 2012 Annual Meeting

被引：18
作者：
Armstrong, April W. [1 ]
Gelfand, Joel M. [2 ]
Boehncke, Wolf-Henning [3 ]
Armstrong, Ehrin J. [4 ]
机构：
[1] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95816 USA
[2] Univ Penn Hlth Syst, Philadelphia, PA USA
[3] Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland
[4] Univ Calif Davis, Div Cardiovasc Med, Sacramento, CA 95816 USA
来源：
JOURNAL OF RHEUMATOLOGY | 2013年 / 40卷 / 08期
关键词：
CARDIOVASCULAR COMORBIDITIES; PSORIASIS; BIOLOGICS; PSORIATIC ARTHRITIS; TUMOR NECROSIS FACTOR INHIBITORS; COMPARATIVE EFFECTIVENESS; MYOCARDIAL-INFARCTION; RHEUMATOID-ARTHRITIS; INSULIN-RESISTANCE; METABOLIC SYNDROME; DIABETES-MELLITUS; INCREASED RISK; DISEASE; ASSOCIATION; MODERATE; THERAPY;
D O I：
10.3899/jrheum.130457
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) in Stockholm, Sweden, several GRAPPA members led a panel discussion on cardiovascular (CV) comorbidities of psoriasis and psoriatic arthritis (PsA). The panelists discussed the role of insulin resistance in the pathophysiology of psoriasis, the possible effect of tumor necrosis factor inhibitors on CV comorbidities, and the effect of 12/23 monoclonal antibodies on CV outcomes. The panelists also addressed how lessons from CV comorbidity research could be applied to other areas of comorbidity research in psoriasis and PsA and identified future research directions in this area.
引用
收藏
页码：1434 / 1437
页数：4
相关论文
共 39 条
  • [31] EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
    Peters, M. J. L.
    Symmons, D. P. M.
    McCarey, D.
    Dijkmans, B. A. C.
    Nicola, P.
    Kvien, T. K.
    McInnes, I. B.
    Haentzschel, H.
    Gonzalez-Gay, M. A.
    Provan, S.
    Semb, A.
    Sidiropoulos, P.
    Kitas, G.
    Smulders, Y. M.
    Soubrier, M.
    Szekanecz, Z.
    Sattar, N.
    Nurmohamed, M. T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (02) : 325 - 331
  • [32] Qureshi AA, 2009, ARCH DERMATOL, V145, P379, DOI 10.1001/archdermatol.2009.48
  • [33] Reich K, 2012, J DRUGS DERMATOL, V11, P300
  • [34] Association Between Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events A Meta-analysis of Randomized Controlled Trials
    Ryan, Caitriona
    Leonardi, Craig L.
    Krueger, James G.
    Kimball, Alexa B.
    Strober, Bruce E.
    Gordon, Kenneth B.
    Langley, Richard G.
    de Lemos, James A.
    Daoud, Yahya
    Blankenship, Derek
    Kazi, Salahuddin
    Kaplan, Dan H.
    Friedewald, Vincent E.
    Menter, Alan
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (08): : 864 - 871
  • [35] Association Between Disease-Modifying Antirheumatic Drugs and Diabetes Risk in Patients With Rheumatoid Arthritis and Psoriasis
    Solomon, Daniel H.
    Massarotti, Elena
    Garg, Rajesh
    Liu, Jun
    Canning, Claire
    Schneeweiss, Sebastian
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (24): : 2525 - 2531
  • [36] Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis
    Taleb, Soraya
    Romain, Melissa
    Ramkhelawon, Bhama
    Uyttenhove, Catherine
    Pasterkamp, Gerard
    Herbin, Olivier
    Esposito, Bruno
    Perez, Nicolas
    Yasukawa, Hideo
    Van Snick, Jacques
    Yoshimura, Akihiko
    Tedgui, Alain
    Mallat, Ziad
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (10) : 2067 - 2077
  • [37] Psoriasis is associated with increased intima-media thickness-The Study of Health in Pomerania (SHIP)
    Troitzsch, Paulina
    Markus, Marcello Ricardo Paulista
    Doerr, Marcus
    Felix, Stephan B.
    Juenger, Michael
    Schminke, Ulf
    Schmidt, Carsten-Oliver
    Voelzke, Henry
    Baumeister, Sebastian E.
    Arnold, Andreas
    [J]. ATHEROSCLEROSIS, 2012, 225 (02) : 486 - 490
  • [38] Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials
    Tzellos, T.
    Kyrgidis, A.
    Zouboulis, C. C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (05) : 622 - 627
  • [39] Association Between Tumor Necrosis Factor Inhibitor Therapy and Myocardial Infarction Risk in Patients With Psoriasis
    Wu, Jashin J.
    Poon, Kwun-Yee T.
    Channual, Jennifer C.
    Shen, Albert Yuh-Jer
    [J]. ARCHIVES OF DERMATOLOGY, 2012, 148 (11) : 1244 - 1250
1234